Id |
Description |
Lang |
Type |
Status |
Case? |
Module |
1461227018 |
Pancreatin (substance) |
en |
Fully specified name |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
1481163018 |
Pancreatin |
en |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
5181949011 |
A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-coloured, amorphous powder, having a faint, characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labelled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. |
en |
Definition |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
5182678011 |
A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-colored, amorphous powder, having a faint, characteristic, but not offensive odor. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labeled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. |
en |
Definition |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
1461227018 |
Pancreatin (substance) |
en |
Fully specified name |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
1461227018 |
Pancreatin (substance) |
en |
Fully specified name |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
1481163018 |
Pancreatin |
en |
Synonym (core metadata concept) |
Active |
Only initial character case insensitive (core metadata concept) |
SNOMED CT core |
1481163018 |
Pancreatin |
en |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT core |
5181949011 |
A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-coloured, amorphous powder, having a faint, characteristic, but not offensive odour. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labelled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. |
en |
Definition |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
5182678011 |
A substance containing enzymes, mainly amylase, lipase, and protease, obtained from the pancreas of the hog or of the ox. It is a cream-colored, amorphous powder, having a faint, characteristic, but not offensive odor. Its greatest activities are in neutral or faintly alkaline media; more than traces of mineral acids or large amounts of alkali hydroxides make it inert. An excess of alkali carbonate also inhibits its action. Pancreatin contains, in each mg, not less than 25 USP units of amylase activity, not less than 2 USP units of lipase activity, and not less than 25 USP units of protease activity. Pancreatin of a higher digestive power may be labeled as a whole-number multiple of the 3 minimum activities, or may be diluted with lactose, or with sucrose containing not more than 3.25% of starch, or with pancreatin of lower digestive power. |
en |
Definition |
Active |
Entire term case sensitive (core metadata concept) |
SNOMED CT core |
37741000188116 |
pancréatine |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
37741000188116 |
pancréatine |
fr |
Synonym (core metadata concept) |
Active |
Entire term case insensitive (core metadata concept) |
SNOMED CT Switzerland NRC maintained Module |
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
pancréatine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pancreatin adverse reaction |
Causative agent (attribute) |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to pancreatin (finding) |
Causative agent (attribute) |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin supplements |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin with high lipase capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin e/c tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin e/c granules in capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatin e/c granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
High lipase pancreatin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by pancreatin |
Causative agent (attribute) |
True |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by pancreatin (disorder) |
Causative agent (attribute) |
True |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to pancreatin (finding) |
Causative agent (attribute) |
True |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dehydrocholic acid and pancreatin and simeticone in oral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dehydrocholic acid and pancreatin and simeticone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dehydrocholic acid and pancreatin and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
produit contenant seulement pancréatine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dehydrocholic acid and pancreatin and simeticone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only dehydrocholic acid and dimeticone and pancreatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dehydrocholic acid and dimeticone and pancreatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing dehydrocholic acid and dimeticone and pancreatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pancreatin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |